Key Insights on the Impact of Sacubitril-Valsartan in Canada, Despite Limitations of Registry Data.

McDonald MA, Kok M, Ducharme A, Ezekowitz J, Howlett J, Rojas-Fernandez C, Udell JA

Open source

DOI
10.1016/j.cjco.2026.04.018
Published
2026 Jul
Container
CJC open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cjco.2026.04.018,
  title = {Key Insights on the Impact of Sacubitril-Valsartan in Canada, Despite Limitations of Registry Data.},
  author = {McDonald MA and Kok M and Ducharme A and Ezekowitz J and Howlett J and Rojas-Fernandez C and Udell JA},
  year = {2026},
  journal = {CJC open},
  doi = {10.1016/j.cjco.2026.04.018},
  url = {https://doi.org/10.1016/j.cjco.2026.04.018}
}

RIS

TY  - JOUR
TI  - Key Insights on the Impact of Sacubitril-Valsartan in Canada, Despite Limitations of Registry Data.
AU  - McDonald MA
AU  - Kok M
AU  - Ducharme A
AU  - Ezekowitz J
AU  - Howlett J
AU  - Rojas-Fernandez C
AU  - Udell JA
PY  - 2026
JO  - CJC open
DO  - 10.1016/j.cjco.2026.04.018
UR  - https://doi.org/10.1016/j.cjco.2026.04.018
ER  - 

APA

MA, M., M, K., A, D., J, E., J, H., C, R., & JA, U. (2026). Key Insights on the Impact of Sacubitril-Valsartan in Canada, Despite Limitations of Registry Data.. CJC open. https://doi.org/10.1016/j.cjco.2026.04.018

Source records